Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.51 USD | -4.68% | +1.23% | -5.96% |
May. 20 | Pulse Biosciences Moves New Record Date for Rights Offering | MT |
May. 14 | Pulse Biosciences Appoints Burke Barrett as President, CEO | MT |
Financials (USD)
Sales 2022 | 0.7 | Sales 2023 | - | Capitalization | 674M |
---|---|---|---|---|---|
Net income 2022 | -58M | Net income 2023 | -42M | EV / Sales 2022 | 168,485,877 x |
Net Debt 2022 | 14.82M | Net cash position 2023 | 35.22M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.61
x | P/E ratio 2023 |
-13.9
x | Employees | 56 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 29.6% |
Latest transcript on Pulse Biosciences, Inc.
1 day | -4.48% | ||
1 week | +1.23% | ||
Current month | -0.35% | ||
1 month | +42.98% | ||
3 months | +12.07% | ||
6 months | +25.66% | ||
Current year | -5.96% |
Managers | Title | Age | Since |
---|---|---|---|
Burke T. Barrett
CEO | Chief Executive Officer | - | May. 11 |
Chief Tech/Sci/R&D Officer | - | 23-05-02 | |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Duggan
CHM | Chairman | 79 | 17-11-01 |
Director/Board Member | 46 | 17-11-01 | |
Darrin Uecker
CTO | Chief Tech/Sci/R&D Officer | 58 | 15-09-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.36% | 4 M€ | -5.15% | - | |
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 11.55 | -4.15% | 277,032 |
24-05-30 | 12.05 | -4.52% | 486,848 |
24-05-29 | 12.62 | -5.26% | 434,190 |
24-05-28 | 13.32 | +17.15% | 390,407 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-5.96% | 638M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- PLSE Stock